Variant report

Variant	esv3342953
Chromosome Location	chr18:30350854-30353352
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:91)
CpG islands
(count:977)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:91 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BRCA1	chr18:30351008-30351125	HepG2	liver:	n/a	n/a
2	CEBPD	chr18:30351440-30351711	HepG2	liver:	n/a	n/a
3	CHD1	chr18:30351193-30351527	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr18:30352051-30352232	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr18:30351912-30351993	HepG2	liver:	n/a	n/a
6	CHD2	chr18:30351305-30351662	HepG2	liver:	n/a	n/a
7	CHD2	chr18:30349596-30351039	HepG2	liver:	n/a	n/a
8	CHD2	chr18:30352230-30352327	HepG2	liver:	n/a	n/a
9	CTBP2	chr18:30350782-30352343	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr18:30351500-30351650	HEK293	kidney:	n/a	n/a
11	ELF1	chr18:30351404-30351723	HepG2	liver:	n/a	n/a
12	EP300	chr18:30352701-30353370	ECC-1	luminal epithelium:	n/a	chr18:30352890-30352904
13	EP300	chr18:30352531-30353547	ECC-1	luminal epithelium:	n/a	chr18:30352890-30352904
14	HDAC2	chr18:30350272-30350999	HepG2	liver:	n/a	n/a
15	HEY1	chr18:30349545-30351734	HepG2	liver:	n/a	n/a
16	HEY1	chr18:30351777-30352364	HepG2	liver:	n/a	n/a
17	HEY1	chr18:30352876-30353062	HepG2	liver:	n/a	n/a
18	HEY1	chr18:30350643-30351715	HepG2	liver:	n/a	n/a
19	HNF4A	chr18:30349321-30351064	HepG2	liver:	n/a	chr18:30349419-30349431
20	HNF4A	chr18:30350630-30350922	HepG2	liver:	n/a	n/a
21	HNF4A	chr18:30350602-30350964	HepG2	liver:	n/a	n/a
22	HNF4G	chr18:30350640-30350894	HepG2	liver:	n/a	n/a
23	KAP1	chr18:30352645-30353085	HEK293	kidney:	n/a	n/a
24	KAP1	chr18:30352692-30352991	U2OS	brain:	n/a	n/a
25	MAX	chr18:30351043-30351812	ECC-1	luminal epithelium:	n/a	chr18:30351760-30351770
26	MAX	chr18:30350366-30350869	HepG2	liver:	n/a	n/a
27	MAZ	chr18:30351534-30351707	HepG2	liver:	n/a	n/a
28	MAZ	chr18:30353290-30353631	HepG2	liver:	n/a	n/a
29	MXI1	chr18:30349162-30351185	HepG2	liver:	n/a	n/a
30	MYBL2	chr18:30351080-30351761	HepG2	liver:	n/a	n/a
31	PAX5	chr18:30352872-30353162	GM12891	blood:	n/a	n/a
32	PAX5	chr18:30352851-30353144	GM12878	blood:	n/a	n/a
33	POLR2A	chr18:30349464-30352352	HepG2	liver:	n/a	n/a
34	POLR2A	chr18:30351307-30351727	PANC-1	pancreas:	n/a	n/a
35	POLR2A	chr18:30351110-30352334	HepG2	liver:	n/a	n/a
36	POLR2A	chr18:30350679-30350981	HepG2	liver:	n/a	n/a
37	POLR2A	chr18:30351871-30352017	HepG2	liver:	n/a	n/a
38	POLR2A	chr18:30350818-30351619	HepG2	liver:	n/a	n/a
39	POLR2A	chr18:30352894-30353142	HepG2	liver:	n/a	n/a
40	POLR2A	chr18:30350694-30351728	ECC-1	luminal epithelium:	n/a	n/a
41	POLR2A	chr18:30350672-30350910	HepG2	liver:	n/a	n/a
42	POLR2A	chr18:30349164-30351097	HepG2	liver:	n/a	n/a
43	POLR2A	chr18:30350668-30351744	HepG2	liver:	n/a	n/a
44	POLR2A	chr18:30350658-30351743	HepG2	liver:	n/a	n/a
45	POLR2A	chr18:30353307-30353427	HepG2	liver:	n/a	n/a
46	POLR2A	chr18:30351098-30351266	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr18:30350612-30352461	ECC-1	luminal epithelium:	n/a	n/a
48	POLR2A	chr18:30351164-30352556	HEK293	kidney:	n/a	n/a
49	POLR2A	chr18:30352607-30353069	HepG2	liver:	n/a	n/a
50	POLR2A	chr18:30348684-30352312	HepG2	liver:	n/a	n/a

(count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr18:30352297-30352347	RPTEC	kidney:	n/a
2	chr18:30352297-30352347	RPTEC	kidney:	n/a
3	chr18:30353073-30353123	AG04449	skin:	fetal
4	chr18:30352505-30352555	PFSK-1	brain:	n/a
5	chr18:30352980-30353030	PFSK-1	brain:	n/a
6	chr18:30352975-30353025	CMK	blood:	n/a
7	chr18:30353283-30353333	Jurkat	blood:	n/a
8	chr18:30352505-30352555	AG04450	lung:	fetal
9	chr18:30351472-30351522	MCF-7	breast:	n/a
10	chr18:30352782-30352832	AG09309	skin:	n/a
11	chr18:30353283-30353333	BJ	skin:	n/a
12	chr18:30352975-30353025	AG04449	skin:	fetal
13	chr18:30353125-30353175	PANC-1	pancreas:	n/a
14	chr18:30353000-30353050	HUVEC	blood vessel:	n/a
15	chr18:30351342-30351392	NHBE	bronchial:	n/a
16	chr18:30350977-30351027	HCM	heart:	n/a
17	chr18:30353073-30353123	BE2_C	brain:	n/a
18	chr18:30352975-30353025	AG04450	lung:	fetal
19	chr18:30353283-30353333	Hela-S3	cervix:	n/a
20	chr18:30350977-30351027	GM12892	blood:	n/a
21	chr18:30353073-30353123	HAEpiC	amniotic membrane:	n/a
22	chr18:30352505-30352555	GM06990	blood:	n/a
23	chr18:30352782-30352832	HCF	heart:	n/a
24	chr18:30351342-30351392	HNPCEpiC	eye:	n/a
25	chr18:30351472-30351522	NHBE	bronchial:	n/a
26	chr18:30352975-30353025	HRCEpiC	kidney:	n/a
27	chr18:30352975-30353025	SK-N-MC	brain:	n/a
28	chr18:30352297-30352347	T-47D	breast:	n/a
29	chr18:30351983-30352033	HCF	heart:	n/a
30	chr18:30353000-30353050	SKMC	muscle:	n/a
31	chr18:30353073-30353123	MCF-7	breast:	n/a
32	chr18:30352297-30352347	AG09309	skin:	n/a
33	chr18:30350935-30350985	AG10803	skin:	n/a
34	chr18:30350977-30351027	SK-N-SH	brain:	n/a
35	chr18:30353125-30353175	GM19239	blood:	n/a
36	chr18:30351983-30352033	U87	brain:	n/a
37	chr18:30351214-30351264	HPAEpiC	pulmonary alveolar:	n/a
38	chr18:30352980-30353030	A549	lung:	n/a
39	chr18:30353073-30353123	HCM	heart:	n/a
40	chr18:30351983-30352033	RPTEC	kidney:	n/a
41	chr18:30352505-30352555	K562	blood:	n/a
42	chr18:30353073-30353123	HUVEC	blood vessel:	n/a
43	chr18:30351342-30351392	HCF	heart:	n/a
44	chr18:30352782-30352832	Caco-2	colon:	n/a
45	chr18:30353125-30353175	Caco-2	colon:	n/a
46	chr18:30352975-30353025	A549	lung:	n/a
47	chr18:30350977-30351027	NT2-D1	testis:	n/a
48	chr18:30351983-30352033	H1-hESC	embryonic stem cell:	embryo
49	chr18:30351214-30351264	HCM	heart:	n/a
50	chr18:30352782-30352832	ProgFib	skin:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr18:30348555..30351173-chr18:30358732..30360847,2	MCF-7	breast:

No data

Variant related genes	Relation type
KLHL14	TF binding region
KLHL14	CpG island
ENSG00000243355	chromatin interactions

Extended variants
information (count: 68 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:68 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111576896	chr18:30350905-30350906	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs560726054	chr18:30350968-30350969	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs114037252	chr18:30350978-30350979	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs141733409	chr18:30350987-30350988	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs192114706	chr18:30351030-30351031	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs564126666	chr18:30351068-30351069	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs559652748	chr18:30351104-30351105	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs185350575	chr18:30351126-30351127	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs551578006	chr18:30351155-30351156	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs189756857	chr18:30351207-30351208	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs77270535	chr18:30351224-30351225	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs549409338	chr18:30351298-30351299	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs7229745	chr18:30351310-30351311	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs535054045	chr18:30351312-30351313	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs192772902	chr18:30351316-30351317	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs374908947	chr18:30351323-30351324	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs113012489	chr18:30351336-30351337	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs578015293	chr18:30351337-30351338	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs538901681	chr18:30351359-30351360	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs557205888	chr18:30351374-30351375	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs368349668	chr18:30351387-30351388	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs575352634	chr18:30351424-30351425	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs62092151	chr18:30351439-30351440	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs561081328	chr18:30351449-30351450	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs572833622	chr18:30351547-30351548	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs539868446	chr18:30351563-30351564	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
27	rs142842927	chr18:30351568-30351569	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
28	rs564509247	chr18:30351579-30351580	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
29	rs533459333	chr18:30351613-30351614	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs376022965	chr18:30351617-30351618	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs563733297	chr18:30351648-30351649	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs531181298	chr18:30351693-30351694	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs549300563	chr18:30351833-30351834	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs567777036	chr18:30351837-30351838	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs535093133	chr18:30351856-30351857	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs547032608	chr18:30351895-30351896	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs538939451	chr18:30351918-30351919	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs557342961	chr18:30351950-30351951	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs7234849	chr18:30351955-30351956	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs536479207	chr18:30351979-30351980	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs554443142	chr18:30351984-30351985	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs200605696	chr18:30352058-30352059	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs147250782	chr18:30352078-30352079	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs572915149	chr18:30352079-30352080	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs539904699	chr18:30352083-30352084	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs71366355	chr18:30352114-30352115	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs549220428	chr18:30352180-30352181	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs576380910	chr18:30352303-30352304	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs7235260	chr18:30352363-30352364	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs564050752	chr18:30352489-30352490	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Esophageal squamous carcinoma	18350619	CNVD
Follicular lymphoma	20505157	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	18923191	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Trisomy 18 syndrome	17576883	CNVD
lymphocytic leukemia	21291569	CNVD
Barrett''s syndrome	19417022	CNVD
Ewing''s sarcoma	17952124	CNVD
Multiple myeloma	17550852	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Glioblastoma multiforme	21922591	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
18q deletion syndrome	19533772	CNVD
Acute myeloid leukemia	16864856	CNVD
Colorectal cancer	21102417	CNVD
Colorectal cancer	20709793	CNVD
Pancreatic cancer	21811562	CNVD
Basal cell lymphoma	21115979	CNVD
Mucosa-associated lymphoid tissue lymphomas	21459788	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
colon cancer	17210682	CNVD
Breast cancer	21785460	CNVD
Hepatocellular carcinoma	16750200	CNVD
Prostate cancer	16573809	CNVD
Autism	16446308	CNVD
Colorectal cancer	19359472	CNVD
Colorectal cancer	16272173	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	18056178	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17133270	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Colorectal cancer	16774939	CNVD
Colorectal cancer	21297112	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Glioblastoma multiforme	17002787	CNVD
Cancer	21183584	CNVD
Breast cancer	17603634	CNVD
Thyroid cancer	19087340	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Colorectal cancer	16912164	CNVD
Renal cell carcinoma	19150565	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19150955	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	21811587	CNVD
Prostate cancer	22341455	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:312 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr18:30348800-30351000	Bivalent/Poised TSS	Primary Natural Killer cells fromperipheralblood	blood
2	chr18:30348800-30353600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
3	chr18:30349200-30351200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
4	chr18:30349200-30351600	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr18:30349200-30352600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr18:30349200-30353600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
7	chr18:30349400-30351600	Bivalent/Poised TSS	Fetal Brain Female	brain
8	chr18:30349400-30352400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
9	chr18:30349400-30352600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
10	chr18:30349400-30352600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
11	chr18:30349400-30352600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
12	chr18:30349600-30351000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr18:30349600-30351400	Flanking Active TSS	Right Ventricle	heart
14	chr18:30349600-30352000	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
15	chr18:30349600-30352200	Bivalent/Poised TSS	Small Intestine	intestine
16	chr18:30349600-30352400	Active TSS	Pancreatic Islets	Pancreatic Islet
17	chr18:30349600-30352400	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
18	chr18:30349600-30352600	Bivalent/Poised TSS	Psoas Muscle	Psoas
19	chr18:30349800-30351000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr18:30349800-30351000	Bivalent Enhancer	Fetal Intestine Large	intestine
21	chr18:30349800-30351400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
22	chr18:30349800-30351600	Bivalent Enhancer	Stomach Mucosa	stomach
23	chr18:30349800-30352000	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
24	chr18:30349800-30352400	Bivalent/Poised TSS	Primary mononuclear cells fromperipheralblood	Blood
25	chr18:30350000-30351000	Bivalent/Poised TSS	Primary hematopoietic stem cells	blood
26	chr18:30350000-30351000	Bivalent/Poised TSS	Primary T helper cells fromperipheralblood	blood
27	chr18:30350000-30351000	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
28	chr18:30350000-30351200	Bivalent Enhancer	Fetal Lung	lung
29	chr18:30350000-30351600	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
30	chr18:30350200-30351200	Bivalent Enhancer	Fetal Brain Male	brain
31	chr18:30350200-30351400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr18:30350200-30351400	Active TSS	Right Atrium	heart
33	chr18:30350200-30351600	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr18:30350200-30352400	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr18:30350200-30352400	Active TSS	HepG2	liver
36	chr18:30350200-30352600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
37	chr18:30350200-30352800	Active TSS	Fetal Kidney	kidney
38	chr18:30350400-30351800	Bivalent Enhancer	HMEC	breast
39	chr18:30350600-30351000	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr18:30350600-30351000	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
41	chr18:30350600-30351200	Flanking Active TSS	Primary B cells from cord blood	blood
42	chr18:30350600-30351400	Bivalent/Poised TSS	Spleen	Spleen
43	chr18:30350600-30351600	Enhancers	Fetal Heart	heart
44	chr18:30350600-30352600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
45	chr18:30350600-30352600	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
46	chr18:30350800-30351000	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr18:30350800-30351000	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr18:30350800-30351000	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
49	chr18:30350800-30351000	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
50	chr18:30350800-30351000	Bivalent/Poised TSS	Primary T cells effector/memory enriched fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links